Biophytis has Requested a Pre-Submission Meeting with the FD

PARIS, FRANCE and CAMBRIDGE, MA / ACCESSWIRE / July 20, 2023 / Biophytis SA (Nasdaq CM:BPTS)(PARIS:ALBPS), ("Biophytis"), a clinical-stage biotechnology company specialized in the development of therapeutics

Related Keywords

United States , Paris , France General , France , Cambridge , Cambridgeshire , United Kingdom , Massachusetts , Veillet , Rhôalpes , Antoine Denry , Agathe Boggio , Nizar Berrada , Nicolas Fellmann , Exchange Commission , Drug Administration , European Medicine Agency , Emergency Use Authorization , Chief Executive Officer , Acute Respiratory Distress Syndrome , Emergency Use Application , Duchenne Muscular Dystrophy , Euronext Growth , American Depositary Shares , Nasdaq Capital Market ,